10/09/2026
🌿 "Preventative healthcare isn't a luxury - it's the bedrock of a resilient NHS."
For people with Pernicious Anaemia, this couldn't be more relevant.
PA is an autoimmune condition. The immune system attacks the cells that allow B12 to be absorbed - meaning no amount of dietary change fixes it. Replacement therapy, usually in the form of injections, is required for life.
That's not a burden patients chose. But how that treatment is delivered? That's something we can change.
Right now, most PA patients get a clinical appointment every 8 to 12 weeks - a nurse or GP visit, repeated indefinitely, for a treatment that many patients could safely manage themselves.
Self-administration makes lifelong treatment sustainable - for patients and for the NHS.
Fewer clinical appointments means freed-up NHS time and resources
Treatment at the right frequency - guided by symptoms, not a fixed date - means better outcomes and fewer complications
Less travel and fewer appointments means less disruption to patients' working and family lives
Greater independence means better quality of life
And as research into alternative B12 delivery methods develops - from pharmacy access to technologies like microneedles - the opportunity grows to make lifelong autoimmune treatment more flexible, more accessible, and more sustainable for everyone who needs it.
This is exactly the kind of systemic patient led thinking that the Pernicious Anaemia Society represents. ✨
We are beginning to see NHS trusts listen to our evidence and logic! Let's keep pushing.
This is the year things change.
